US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
AMEX
NanoViricides Inc (NNVC)
NanoViricides Inc (NNVC) ニュース

NNVC

NanoViricides (NNVC)

NanoViricides Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:NNVC

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/02	23 : 07	InvestorsHub NewsWire	NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon	AMEX:NNVC	NanoViricides Inc
2024/02/17	06 : 53	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NNVC	NanoViricides Inc
2024/02/15	06 : 55	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NNVC	NanoViricides Inc
2024/01/20	06 : 44	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NNVC	NanoViricides Inc
2023/12/05	06 : 08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:NNVC	NanoViricides Inc
2023/10/14	05 : 30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	AMEX:NNVC	NanoViricides Inc
2023/09/29	05 : 44	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	AMEX:NNVC	NanoViricides Inc
2023/09/02	05 : 46	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NNVC	NanoViricides Inc
2023/07/07	00 : 16	InvestorsHub NewsWire	Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs	AMEX:NNVC	NanoViricides Inc
2023/05/26	05 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:NNVC	NanoViricides Inc
2023/05/09	06 : 20	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	AMEX:NNVC	NanoViricides Inc
2023/05/04	19 : 45	GlobeNewswire Inc.	NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City	AMEX:NNVC	NanoViricides Inc
2023/02/15	07 : 24	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:NNVC	NanoViricides Inc
2023/02/14	07 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:NNVC	NanoViricides Inc
2022/12/23	20 : 04	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	AMEX:NNVC	NanoViricides Inc
2022/11/16	06 : 32	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	AMEX:NNVC	NanoViricides Inc
2022/11/05	05 : 33	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	AMEX:NNVC	NanoViricides Inc
2022/10/14	06 : 13	Edgar (US Regulatory)	Annual Report (10-k)	AMEX:NNVC	NanoViricides Inc
2022/09/30	01 : 20	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	AMEX:NNVC	NanoViricides Inc
2022/08/11	07 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:NNVC	NanoViricides Inc
2022/05/17	05 : 55	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:NNVC	NanoViricides Inc
2021/11/16	06 : 55	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:NNVC	NanoViricides Inc
2021/11/15	21 : 09	InvestorsHub NewsWire	NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2	AMEX:NNVC	NanoViricides Inc
2021/10/12	19 : 16	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	AMEX:NNVC	NanoViricides Inc
2021/10/11	19 : 49	InvestorsHub NewsWire	NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity	AMEX:NNVC	NanoViricides Inc
2021/10/05	19 : 45	PR Newswire (US)	NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference	AMEX:NNVC	NanoViricides Inc
2021/10/05	19 : 45	PR Newswire (US)	NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference	AMEX:NNVC	NanoViricides Inc
2021/09/29	05 : 32	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	AMEX:NNVC	NanoViricides Inc
2021/09/22	19 : 48	InvestorsHub NewsWire	Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug	AMEX:NNVC	NanoViricides Inc
2021/09/22	19 : 45	PR Newswire (US)	Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug	AMEX:NNVC	NanoViricides Inc

Showing the most relevant articles for your search:AMEX:NNVC

1 2 3 4 5 6 7 8 9 10 次へ >>

Kontrol Technologies (QB)

Harvest Minerals (PK)

Amundi Etf Short Euro St...

ETFis Series Trust I

Naos Emerging Opportunit...

First Citizens BancShares

Elcora Advanced Materials (PK)

Spdr Marketaxess Investm...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約